2024 UPMC Hillman Cancer Center: Advancements in Head and Neck Cancer Symposium

Event Overview

The goal of this conference is to provide healthcare professionals with the knowledge on new and updated treatment for patients with head and neck cancer. The audience will be multidisciplinary and consist of oncology physicians, registered nurses, advanced practice providers, social workers, and other healthcare providers working with head and neck cancer patients. There are in person and virtual options for attendance. This conference is sponsored by the University of Pittsburgh School of Medicine Center for Continuing Education in the Health Sciences and UPMC Hillman Cancer Center.

Course Directors

The course directors for the event are Matthew Spector, MD, Christopher Wilke, MD, and Dan Zandberg, MD.

Course Objectives

Upon completion of this program, attendees will be able to:

• Discuss the standard of care evaluation and treatment of squamous cell carcinoma of the oral cavity, oropharynx (HPV negative), larynx, hypopharynx, nasopharynx, and paranasal sinus.
• Discuss the standard of care evaluation and treatment of HPV positive oropharyngeal squamous cell carcinoma.
• Discuss the standard of care evaluation and treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
• Describe new developments in clinical, translational, and basic immunology in head and neck cancer.

Tuition and Registration

Tuition for physicians is $75.00. Tuition for all other medical professionals is $35.00. There is no fee for students. For more information, contact Lynne O’Connor at oconnorlj@upmc.edu. Course brochure and registration are available at http://cce.upmc.com. Registration deadline is Friday, October 18, 2024. Cancellations received before Friday, October 18, 2024, will be refunded in full. After Friday, October 18, 2024, no refunds will be made.

Agenda and Conference Details

View the full agenda here.